77783471 - GLENERIC

Information

• Trademark
• 77783471

• Source

• Serial Number

  77783471

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  July 17, 2009
  15 years ago

• Transaction Date

  May 14, 2012
  12 years ago

• Status Date

  May 14, 2012
  12 years ago

• Published for Opposition Date

  August 17, 2010
  14 years ago

• Location Date

  October 13, 2011
  13 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  CAPSHAW, DANIEL

• Attorney Docket Number

  12890/

  Attorney Name

  Howard J. Shire

  Law Office Assigned Location Code

  M10

• Owners

  • Glenmark Pharmaceuticals Limited

Case File Statements

• GS0051: Pharmaceuticals and Medicinal preparations, namely, opium alkaloid preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, anticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint disease; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelmintics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; preparation for the relief of pain

Case File Event Statements

• 5/14/2012 - 12 years ago

  38 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6

• 5/14/2012 - 12 years ago

  37 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 10/15/2011 - 13 years ago

  36 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 10/14/2011 - 13 years ago

  35 - EXTENSION 2 GRANTED Type: EX2G

• 10/12/2011 - 13 years ago

  34 - EXTENSION 2 FILED Type: EXT2

• 10/13/2011 - 13 years ago

  33 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 10/12/2011 - 13 years ago

  32 - TEAS EXTENSION RECEIVED Type: EEXT

• 3/9/2011 - 14 years ago

  31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 3/7/2011 - 14 years ago

  30 - EXTENSION 1 GRANTED Type: EX1G

• 3/7/2011 - 14 years ago

  29 - EXTENSION 1 FILED Type: EXT1

• 3/7/2011 - 14 years ago

  28 - TEAS EXTENSION RECEIVED Type: EEXT

• 10/12/2010 - 14 years ago

  27 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 8/17/2010 - 14 years ago

  26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/17/2010 - 14 years ago

  25 - PUBLISHED FOR OPPOSITION Type: PUBO

• 7/9/2010 - 14 years ago

  24 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 7/8/2010 - 14 years ago

  23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/9/2010 - 14 years ago

  22 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 6/9/2010 - 14 years ago

  21 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 6/9/2010 - 14 years ago

  20 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 6/9/2010 - 14 years ago

  19 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 6/5/2010 - 14 years ago

  18 - DATA MODIFICATION COMPLETED Type: DMCC

• 6/3/2010 - 14 years ago

  17 - ASSIGNED TO LIE Type: ALIE

• 5/27/2010 - 14 years ago

  16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/27/2010 - 14 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/27/2010 - 14 years ago

  14 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 4/27/2010 - 15 years ago

  13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 4/27/2010 - 15 years ago

  12 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 4/27/2010 - 15 years ago

  11 - SUSPENSION LETTER WRITTEN Type: CNSL

• 4/14/2010 - 15 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/14/2010 - 15 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/14/2010 - 15 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/20/2009 - 15 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 10/20/2009 - 15 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 10/20/2009 - 15 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/20/2009 - 15 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 7/22/2009 - 15 years ago

  3 - NOTICE OF PSEUDO MARK MAILED Type: MPMK

• 7/21/2009 - 15 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 7/21/2009 - 15 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP